Department of Obstetrics, Gynecology and Reproductive Sciences, University of California-San Francisco, CA 94105, USA.
BJOG. 2013 Sep;120(10):1233-9. doi: 10.1111/1471-0528.12258. Epub 2013 May 7.
We sought to examine the impact of the loop electrosurgical excision procedure (LEEP) on the rate and magnitude of HIV-1 genital shedding among women undergoing treatment for cervical intraepithelial neoplasia 2/3 (CIN2/3).
Prospective cohort study.
Women infected with HIV-1 undergoing LEEP for CIN2/3 in Kisumu, Kenya.
Participants underwent specimen collection for HIV-1 RNA prior to LEEP and at 1, 2, 4, 6, 10, and 14 weeks post-LEEP. HIV-1 viral load was measured in cervical and plasma specimens using commercial real-time polymerase chain reaction (PCR) assays, to a lower limit of detection of 40 copies per specimen.
Presence and magnitude of HIV-1 RNA (copies per specimen or cps) in post-LEEP specimens, compared with baseline.
Among women on highly active antiretroviral therapy (HAART), we found a statistically significant increase in cervical HIV-1 RNA concentration at week 2, with a mean increase of 0.43 log10 cps (95% CI 0.03-0.82) from baseline. Similarly, among women not receiving HAART, we found a statistically significant increase in HIV-1 shedding at week 2 (1.26 log10 cps, 95% CI 0.79-1.74). No other statistically significant increase in concentration or detection of cervical HIV-1 RNA at any of the remaining study visits were noted.
In women infected with HIV undergoing LEEP, an increase in genital HIV shedding was observed at 2 but not at 4 weeks post-procedure. The current recommendation for women to abstain from vaginal intercourse for 4 weeks seems adequate to reduce the theoretical increased risk of HIV transmission following LEEP.
我们旨在研究环形电切术(LEEP)对接受宫颈上皮内瘤变 2/3(CIN2/3)治疗的女性中 HIV-1 生殖器脱落率和脱落量的影响。
前瞻性队列研究。
在肯尼亚基苏木感染 HIV-1 并接受 LEEP 治疗 CIN2/3 的女性。
参与者在 LEEP 治疗前和治疗后 1、2、4、6、10 和 14 周时进行 HIV-1 RNA 标本采集。使用商业实时聚合酶链反应(PCR)检测试剂盒,在宫颈和血浆标本中检测 HIV-1 病毒载量,检测下限为每个标本 40 拷贝。
LEEP 后标本中 HIV-1 RNA(每份标本或拷贝数,cps)的存在和量,与基线相比。
在接受高效抗逆转录病毒治疗(HAART)的女性中,我们发现第 2 周宫颈 HIV-1 RNA 浓度有统计学意义的增加,与基线相比平均增加 0.43 log10 cps(95%置信区间 0.03-0.82)。同样,在未接受 HAART 的女性中,我们发现第 2 周 HIV-1 脱落有统计学意义的增加(1.26 log10 cps,95%置信区间 0.79-1.74)。在其余研究访视中,未发现宫颈 HIV-1 RNA 浓度或检测的任何其他有统计学意义的增加。
在接受 LEEP 治疗的感染 HIV 的女性中,在术后 2 周观察到生殖器 HIV 脱落增加,但在术后 4 周时未观察到增加。目前建议女性在术后 4 周内避免阴道性交,以减少 LEEP 后 HIV 传播的理论风险增加。